Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05326113Recruiting
Randomised, open-label trial (2 arms), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Proton Pump Inhibitor Usage. Started Oct 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05326113.